Surims Ltd Logo
 
 
 
 
 
 
Johnson & Johnson Logo  
 
 
Basic Profile
 
If you'd like to claim this company profile for Johnson & Johnson, please Contact Us.
 

Johnson & Johnson News

The latest news, announcements and press releases from Johnson & Johnson.

 
 
06
April
2021
06th April 2021
 

U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca

(Reuters) - The United States has put Johnson and Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and has stopped British drugmaker AstraZeneca Plc from using the facility, a senior health official said on Saturday.

 
Read the full story »
 
 
23
October
2018
23rd October 2018
 

New cancer drugs help Johnson & Johnson edges past profit estimates

Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its cancer drugs Zytiga and Imbruvica helped offset falling sales of arthritis treatment Remicade.

 
Read the full story »
 
 
18
October
2017
18th October 2017
 

J&J’s profit beat estimates thanks to new cancer drugs

Gains from its acquisition of Swiss biotech Actelion also helped the bottom line
 
Read the full story »
 
 
19
July
2017
19th July 2017
 

New cancer drugs see Johnson & Johnson lift 2017 profit forecast

Second quarter earnings beat forecasts despite slight fall in pharma division
 
Read the full story »
 
 
18
April
2017
18th April 2017
 

Johnson & Johnson buys Irish stroke care firm in multimillion euro deal

Sale of Neuravi is largest deal for a venture-backed medtech in Europe since 2009
 
Read the full story »
 
 
30
December
2016
30th December 2016
 

J&J discussing breaking up Actelion in acquisition

Negotiations between the two companies had ended earlier this month
 
Read the full story »
 
 
25
November
2016
25th November 2016
 

Johnson and Johnson makes takeover approach for Actelion

Acquisition would add to the $246 billion of pharmaceutical deals announced this year
 
Read the full story »
 
 
19
October
2016
19th October 2016
 

J&J upbeat on future despite threat to sales of key drug

Arthritis drug Remicade faces challenge from Pfizer biosimilar Inflectra despite ongoing patent lawsuit
 
Read the full story »
 
 
20
July
2016
20th July 2016
 

Johnson & Johnson raises 2016 profits forecast

Demand for company’s cancer drug and blood thinner boosts pharmaceutical sales
 
Read the full story »
 
 
13
July
2016
13th July 2016
 

J&J's insulin patch finally heading for launch

Johnson & Johnson has finally announced a launch schedule for its One Touch Via insulin patch - some four years after it was first approved in the US.
 
Read the full story »
 
 
03
May
2016
03rd May 2016
 

Johnson & Johnson to pay $55m in talc-powder trial

Johnson & Johnson has been ordered by a US jury to pay $55m (€47.6m) to a woman who said that using the company's talc-powder products for feminine hygiene caused her to develop ovarian cancer.
 
Read the full story »
 
 
26
April
2016
26th April 2016
 

Johnson & Johnson beats earnings expectations

Maker of Band-Aids and Tylenol nudges up its 2016 sales and earnings forecasts
 
Read the full story »
 
 
20
January
2016
20th January 2016
 

J&J to cut 3,000 jobs in medical devices division

J&J to cut 3,000 jobs in medical devices division
 
Read the full story »
 
 
 

Claim This Profile

This is the News section of the company profile page for Johnson & Johnson on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

 
 
Johnson & Johnson company details, activities, contacts and reviews.
 
Johnson & Johnson partnership and licensing opportunities.
 
Johnson & Johnson latest news, announcements and press releases.
 
Johnson & Johnson documents, images and videos.
 
Johnson & Johnson global factories, offices and locations.
 
Johnson & Johnson legal and financial information.
 
 
 
 
 
 
 

About Us

Surims Ltd is a consultancy established in 2003 supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at https://www.surims.com.

 
 
 

Get in Touch

The Pharmaceutical Services Directory
info@pharmaservicesdirectory.com

 
 

© 2021 Surims Ltd | All Rights Reserved.